Skip to content

Prehabilitation to Improve Cancer Surgery Outcomes

Prehabilitation to Improve Cancer Surgery Outcomes (PICaSO): A Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03502317
Acronym
PICaSO
Enrollment
128
Registered
2018-04-18
Start date
2018-08-14
Completion date
2021-03-31
Last updated
2020-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Cancer, Physical Activity, Prehabilitation, Surgery

Keywords

Prehabilitation, Gastrointestinal Cancer, Physical Activity, Exercise, Surgery

Brief summary

This is a randomized control trial aiming to investigate the use of a prehabilitation regimen for patients undergoing major GI cancer surgery and its effects on measurements of HRQOL, LOS, and post-operative complications. Participants will be randomized to either the Prehabilitation arm or the Usual Care arm (control group). The Prehabilitation arm will be prescribed both physical and psychological prehabilitation prior to undergoing surgery for their GI cancer. The Usual Care arm will be counseled to continue their current level of activity and given the information on exercise as outlined in the Cancer Care Ontario guidelines. Participants in the Usual Care arm will also be given the same activity tracker as patients in the Prehabilitation arm in order to eliminate the activity tracker as an intervention itself. Clinical, patient-reported outcomes and health system outcomes will be evaluated. Outcomes will be measured at consent (baseline), immediately preoperatively, and postoperatively at 1, 3 and 6 months. The investigators will collect measures of recruitment, attrition and self-reported compliance via a log completed by the coordinator during weekly patient phone calls.

Interventions

Physical prehabilitation will comprise a personalized, home-based exercise program designed to meet the Cancer Care Ontario Exercise Guidelines for Cancer Survivors. A Registered Kinesiologist (RKin) will complete a baseline physical assessment and prescribe an individualized multi-modal exercise program consisting of 4-5 days of 30+ minutes of aerobic exercise (brisk walking or equivalent to target heart rate of 40-60% of max) and 2-3 days of moderate intensity resistance training of major muscle groups (8-10 repetitions). Participants will be provided with a Fitbit with a heart rate monitor, resistance bands, and a stability ball. Patients will be required to wear their Fitbit and record the number of steps at the end of each day from randomization to 90 days post-surgery.

BEHAVIORALPsychological Prehabilitation

Psychological prehabilitation will consist of one in-person coaching session of a 'mindfulness' informed intervention conducted by a specially trained RKin. The 40 minute coaching session will include a guided mindfulness session and debriefing. Participants will be asked to practice for 20 minutes twice a day. The patients will be given access to an audio file that will walk them through the 20 minute sessions.

Sponsors

University Health Network, Toronto
CollaboratorOTHER
Mount Sinai Hospital, Canada
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥ 18 years of age * Fluent in English * Able to comply with study procedures & follow-up contained within the consent form * Pathologically or radiologically confirmed diagnosis of a GI cancer * GI cancer must be considered operable * Expected LOS ≥ 5 days as calculated by the validated American College of Surgeons Surgical Risk Calculator * \> 21 days between time of randomization and time of expected surgery * Patient written, informed consent obtained according to ICH GCP guidelines and local regulations

Exclusion criteria

* \< 18 years old * Not fluent in English * Planned resection of bony pelvis, limbs, or major lower extremity neurovascular structures * Significant comorbidity including any of the following: * Canadian Cardiovascular Society class III/IV coronary disease * New York Heart Association class III/IV congestive heart failure * Neurologic or musculoskeletal disorder prohibiting exercise * Major neuropsychiatric disorder

Design outcomes

Primary

MeasureTime frameDescription
Global Health ScoreBaseline to postoperative day 90The primary outcome is the difference between the baseline and 90-day global health score on the European Organization for the Research and Treatment of Cancer (EORTC) QLC-C30

Secondary

MeasureTime frameDescription
Postoperative hospital length of stayLength of stay will be calculated from the date of surgery until to the date of discharge from the hospital, reported in days, assessed up to 6 months postoperatively.The patient's postoperative length of stay will be recorded from the medical records
Changes in functional capacity from baselineBaseline, immediately preoperatively, and postoperatively at 1, 3, and 6 monthsPatients will perform a 6-Minute Walk Test.
Changes in self-reported physical activity from baselineBaseline, immediately preoperatively, and postoperatively at 1, 3, and 6 monthsChanges in self-reported physical activity will be measured using the Godin Leisure-time Exercise Questionnaire
Changes in health-related quality of life from baselineBaseline, immediately preoperatively, and postoperatively at 1, 3, and 6 monthsHRQOL will be measured using the EQ-5D Health Questionnaire
Presence and severity of symptomsBaseline, immediately preoperatively, and postoperatively at 1, 3, and 6 monthsThe presence and severity of nine common symptoms in cancer patients will be examined using the Edmonton Symptom Assessment Scale (ESAS). This self-report measure examines: pain, tiredness, nausea, depression, anxiety, drowsiness, appetite, wellbeing, and shortness of breath.
Presence and severity of postoperative complicationsPostoperatively through to day 30 and day 90The presence and severity of postoperative complications at 30 and 90 days will be recorded from the patient's medical records
Changes in fatigue from baselineBaseline, immediately preoperatively, and postoperatively at 1, 3, and 6 monthsChanges in cancer-specific fatigue will be assessed using the 13-item Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F).
Interference with occupational performance and productivityBaseline, immediately preoperatively, and postoperatively at 1, 3, and 6 monthsThe degree to which the patient's health problems interfere with occupational performance and productivity will be examined using the Work Limitations Questionnaire
Changes in multidimensional social supportBaseline, immediately preoperatively, and postoperatively at 1, 3, and 6 monthsChanges in the perceived availability of multidimensional social support will be evaluated using the Medical Outcomes Study Social Support Scale (MOS-SSS SF-20). The MOS-SSS SF-20 is a 20 item questionnaire that measures physical functioning, social functioning, mental health, current health perceptions, and pain. After reverse scoring of the appropriate items according to the MOS-SSS core scoring manual, a higher value indicates better functioning, health, and more pain in the respective measures. All measure scores are transformed linearly to scales from 0-100, with 100 being the highest score possible.
Changes in attachment (closeness in relationships with others)Baseline, immediately preoperatively, and postoperatively at 1, 3, and 6 monthsThe Experiences in Close Relationships Scale (ECR M16) will be used to examine adult attachment or closeness in both romantic and non-romantic relationships. There are two domains that are measured - attachment anxiety and avoidance. Each domain includes 8 items. Items are scored on a 7 point Likert Scale (1-7). After appropriate reverse scoring, a high score indicates higher attachment anxiety or avoidance.
Health care utilizationpost-operatively at 3 and 6 monthsHealth care utilization will be assessed at the postoperative 3 and 6 month time points using the Health Service Utilization Inventory
Changes in anxiety and depression from baselineBaseline, immediately preoperatively, and postoperatively at 1, 3, and 6 monthsChanges in anxiety and depression will be examined using the Hospital Anxiety and Depression Scale (HADS). HADS assesses anxiety and depression through self-reporting based on the frequency of symptoms over the past week. There are 2 subscales, one for anxiety and for depression, each with 7 items. Items are scored on a 4 point Likert scale (0-3), with the subscale scores being sums of each item (0-21). A higher score is indicative of higher or worse anxiety and depression.

Countries

Canada

Contacts

Primary ContactEmily Taylor
emily.taylor@sinaihealthsystem.ca416-586-4800
Backup ContactRachel Aitken
rachel.aitken@mail.utoronto.ca

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026